Skip to main content
Top
Literature
1.
go back to reference Schulman ST, Ayoub EM (2002) Poststreptococcal reactive arthritis. Curr Opin Rheumatol 14:562–565CrossRef Schulman ST, Ayoub EM (2002) Poststreptococcal reactive arthritis. Curr Opin Rheumatol 14:562–565CrossRef
2.
go back to reference Keitzer R (2005) Acute rheumatic fever (ARF) and poststreptococcal reactive arthritis(PSRA); an update Zeitschrift für. Rheumatologie 64(5):295–307CrossRef Keitzer R (2005) Acute rheumatic fever (ARF) and poststreptococcal reactive arthritis(PSRA); an update Zeitschrift für. Rheumatologie 64(5):295–307CrossRef
3.
go back to reference Ayoub EM, Majeed HA (2001) Poststreptococal reactive arthritis. Curr Opin Rheumatol 12:306–310CrossRef Ayoub EM, Majeed HA (2001) Poststreptococal reactive arthritis. Curr Opin Rheumatol 12:306–310CrossRef
4.
go back to reference Geasch WH (1992) Guidelines for the diagnosis of rheumatic fever Jones Criteria update. JAMA 268(15):2069–2073CrossRef Geasch WH (1992) Guidelines for the diagnosis of rheumatic fever Jones Criteria update. JAMA 268(15):2069–2073CrossRef
5.
go back to reference Jansen TLJ, Anssen M, de Jong AJ, Jeurissen MA (1999) Post-streptococcal reactive arthritis: a clinical and serological description, revealing its distinction from acute rheumatic fever. J Intern Med 245(3):261–267PubMedCrossRef Jansen TLJ, Anssen M, de Jong AJ, Jeurissen MA (1999) Post-streptococcal reactive arthritis: a clinical and serological description, revealing its distinction from acute rheumatic fever. J Intern Med 245(3):261–267PubMedCrossRef
6.
go back to reference Mackie SL, Keat A (2004) Poststreptococcal reactive arthritis: what is it and how do we know? Rheumatology (Oxford) 43(8):949–954CrossRef Mackie SL, Keat A (2004) Poststreptococcal reactive arthritis: what is it and how do we know? Rheumatology (Oxford) 43(8):949–954CrossRef
7.
go back to reference Carlquist JF, Ward RH, Meyer KJ, Husebye D, Feolo M, Anderson JL (1995) Immune response factors in rheumatic heart disease: meta-analysis of HLA-DR associations and evaluation of additional class II alleles. J Am Coll Cardiol. 26(2):452–457PubMedCrossRef Carlquist JF, Ward RH, Meyer KJ, Husebye D, Feolo M, Anderson JL (1995) Immune response factors in rheumatic heart disease: meta-analysis of HLA-DR associations and evaluation of additional class II alleles. J Am Coll Cardiol. 26(2):452–457PubMedCrossRef
8.
go back to reference Koyanagi T, Koga Y, Nishi H, Toshima H, Sasazuki T (1996) DNA typing of HLA class II genes in Japanese patients with rheumatic heart disease. J Mol Cell Cardiol 28(6):1349–1353PubMedCrossRef Koyanagi T, Koga Y, Nishi H, Toshima H, Sasazuki T (1996) DNA typing of HLA class II genes in Japanese patients with rheumatic heart disease. J Mol Cell Cardiol 28(6):1349–1353PubMedCrossRef
9.
go back to reference Guedez Y, Kotby A, El-Demellawy M, Galal A,Thomson G, Zaher S et al (1999) HLA Class II association with rheumatic heart disease are more evident and consistent among clinically homogenous patients. Circulation 99:2784–2790PubMed Guedez Y, Kotby A, El-Demellawy M, Galal A,Thomson G, Zaher S et al (1999) HLA Class II association with rheumatic heart disease are more evident and consistent among clinically homogenous patients. Circulation 99:2784–2790PubMed
10.
go back to reference Ahmed S, Ayoub EM, Scornick JC, Wang CY, She JX. (1998) Poststreptococcal reactive arthritis; clinical characteristics and association with HLA-DR alleles. Arthritis Rheum 41:1092–1102CrossRef Ahmed S, Ayoub EM, Scornick JC, Wang CY, She JX. (1998) Poststreptococcal reactive arthritis; clinical characteristics and association with HLA-DR alleles. Arthritis Rheum 41:1092–1102CrossRef
11.
go back to reference Simonini G, Porfirio M, Cimaz R, Calabri G B, Giani T, Falcini F (2004) Lack of association between the HLA-DRB1 locus and post-streptococcal reactive arthritis and acute rheumatic fever in Italian children. Semin Arthritis Rheum 34(2):553–558PubMedCrossRef Simonini G, Porfirio M, Cimaz R, Calabri G B, Giani T, Falcini F (2004) Lack of association between the HLA-DRB1 locus and post-streptococcal reactive arthritis and acute rheumatic fever in Italian children. Semin Arthritis Rheum 34(2):553–558PubMedCrossRef
12.
go back to reference Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215PubMed Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215PubMed
13.
go back to reference Olerup O, Zetterquist H (1992) HLA-DR typing by PCR amplification with sequence primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching. Tissue Antigens 39:235–245CrossRef Olerup O, Zetterquist H (1992) HLA-DR typing by PCR amplification with sequence primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching. Tissue Antigens 39:235–245CrossRef
14.
go back to reference Woolf B (1955) On estimating the relation between blood group and disease. Ann Hum Genet 19:251–253PubMed Woolf B (1955) On estimating the relation between blood group and disease. Ann Hum Genet 19:251–253PubMed
Metadata
Title
HLA-DR alleles in patients with post-streptococcal reactive arthritis
Authors
Filiz Ekşi Haydardedeoğlu
Hüseyin Tutkak
Kenan Köse
Nurşen Düzgün
Publication date
01-11-2006
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 1/2006
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-006-0170-z

Other articles of this Issue 1/2006

Rheumatology International 1/2006 Go to the issue

Acknowlegedment to Referees

Acknowledgement to Referees

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine